Type 1 diabetes prevention clinical trial simulator: Case reports of model‐informed drug development tool

Type 1 diabetes prevention clinical trial simulator: Case reports of model‐informed drug development tool

Abstract Clinical trials seeking to delay or prevent the onset of type 1 diabetes (T1D) face a series of pragmatic challenges. Despite more than 100 years since the discovery of insulin, teplizumab remains the only FDA‐approved therapy to delay progression from Stage 2 to Stage 3 T1D. To increase th...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan Francisco Morales, Marian Klose, Yannick Hoffert, Jagdeep T. Podichetty, Jackson Burton, Stephan Schmidt, Klaus Romero, Inish O'Doherty, Frank Martin, Martha Campbell‐Thompson, Michael J. Haller, Mark A. Atkinson, Sarah Kim
Format: Article
Language:English
Published: Wiley 2024-08-01
Series:CPT: Pharmacometrics & Systems Pharmacology
Online Access:https://doi.org/10.1002/psp4.13193
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/psp4.13193

Similar Items